Traumatic Optic Neuropathy

Key Points at a Glance

Key Points of This Disease

• Traumatic optic neuropathy is a condition in which the optic nerve in the optic canal is damaged by indirect force from blunt trauma to the eyebrow area.
• Direct injury (direct damage from bone fragments or foreign bodies) is rare; most cases are indirect injuries.
• Severe visual impairment occurs immediately after injury, ranging from no light perception to mild impairment.
• Positive RAPD and decreased CFF are key to diagnosis; the fundus is usually normal immediately after injury.
• Progressive optic atrophy appears 6 to 8 weeks later.
• Early (within 24 to 48 hours after injury) steroid pulse therapy and hyperosmotic agents affect prognosis.
• Cases where light perception does not recover quickly after injury are mostly unresponsive to treatment.

1. What is Traumatic Optic Neuropathy?

Traumatic optic neuropathy is a condition in which a strong blow to the forehead or frontal region, especially the eyebrow area, causes indirect force to act on the optic canal, resulting in contusion of the optic nerve. Previously, optic canal fracture was considered the main cause, but it is now known that it can also occur without fracture. It usually develops after blunt trauma to the outer upper eyebrow, and most cases show subcutaneous hemorrhage or contusion laceration on the lateral side of the eyebrow. Extension of orbital floor fracture to the optic canal or orbital stab wounds can also be causes.

Classification

It is classified by the mechanism of injury as follows:

• Direct injury: Direct damage to the optic nerve by bone fragments or foreign bodies. Relatively rare.
• Indirect injury: Indirect force from a blow to the eyebrow area is transmitted to the optic canal, causing optic nerve contusion. Accounts for the majority of traumatic optic neuropathy.

Classification by injury site is as follows:

• Optic canal traumatic optic neuropathy: Most common; the optic nerve within the optic canal is damaged by indirect force.
• Optic nerve avulsion: Rupture of the optic nerve at the lamina cribrosa. This is a special type with no effective treatment.

Epidemiology

Detailed epidemiological data are scarce. Approximately 20% of optic canal fractures are missed on X-ray and CT, so diagnosis should not be based solely on the presence or absence of fracture. Causes include traffic accidents, sports injuries, falls, and assaults. In children, the possibility of traumatic optic neuropathy due to abuse should also be considered.

Q Does traumatic optic neuropathy always involve a fracture?

A

Fractures are not always present. Traditionally, optic canal fracture was considered the main cause, but it is now known that optic nerve contusion from indirect force can occur without fracture. Since about 20% of optic canal fractures are missed on CT, clinical findings should be emphasized regardless of the presence or absence of fracture.

2. Main Symptoms and Clinical Findings

Subjective Symptoms

The main symptom is visual impairment immediately after injury.

• Visual acuity loss: Ranges from no light perception to mild impairment, but most cases are severe.
• Visual field defects: Various forms including central scotoma, concentric constriction, and horizontal hemianopia.

Clinical Findings

• Positive RAPD (Marcus-Gunn pupil): Direct light reflex is diminished, and the swinging flashlight test is positive. This is the most important finding for diagnosing traumatic optic neuropathy.
• Decreased CFF (critical flicker frequency): Markedly decreased or unmeasurable.
• Fundus findings: Usually normal immediately after injury. After 6–8 weeks, progressive optic atrophy appears, and the optic disc becomes pale.
• OCT findings: GCC (ganglion cell complex) thickness becomes thinner than normal 2 weeks after injury and stabilizes around 30–50 days.
• External findings: Subcutaneous hemorrhage or contusion due to bruising is often observed on the lateral side of the eyebrow.

3. Causes and Risk Factors

Pathophysiology

In the optic canal, the periosteum and dura mater are fused, so there is little mobility to cushion the impact. Therefore, external force easily causes hemorrhage within the optic nerve sheath and edema or rupture of optic nerve fibers.

The mechanism of optic nerve injury is thought to be mainly vasogenic edema within the optic nerve parenchyma (corresponding to the white matter of the brain) caused by contusion. This is similar to brain edema due to head trauma. This edema compresses the optic nerve within the closed bony space of the optic canal, leading to nerve fiber damage.

Risk Factors

• Blunt trauma to the eyebrow or forehead: An essential condition for onset
• Traffic accidents, sports injuries: Main causes in adults
• Falls, assaults: Common causes in the elderly and children
• Child abuse: Always consider in unexplained vision loss in children

Prevention and Daily Care

If you notice vision loss after a bruise to the eyebrow area due to a traffic accident or sports injury, please see an ophthalmologist promptly. Early treatment within 24 to 48 hours after injury greatly affects the prognosis, so it is important to seek medical attention as soon as possible. In cases of unexplained vision loss in children, the possibility of abuse should also be considered.

4. Diagnosis and Examination Methods

Basic Examinations

• Swinging flashlight test: The most important test for diagnosing traumatic optic neuropathy. Confirm a positive RAPD (Marcus-Gunn pupil).
• Visual acuity test: Assesses a range from no light perception to mild reduction.
• Visual field test: Identifies central scotoma, concentric constriction, and horizontal hemianopia.
• CFF (critical flicker frequency) measurement: Shows significant decrease or becomes unmeasurable. Useful for evaluating optic nerve function.

Imaging Tests

• Plain X-ray of optic canal: Used to confirm optic canal fractures, but misses about 20%.
• CT scan: Standard for evaluating optic canal fractures and bone fragment displacement. However, about 20% are undetectable. Also checks for involvement of orbital floor fractures.
• OCT (optical coherence tomography): Evaluates temporal changes in GCC thickness. Thinning begins 2 weeks after injury and stabilizes around 30–50 days. Useful for follow-up.

Differential Diagnosis

The following conditions must be differentiated:

• Non-arteritic anterior ischemic optic neuropathy: Common in elderly, hypertensive, and diabetic patients. No history of trauma.
• Optic neuritis (demyelinating): Often accompanied by pain with eye movement. More common in young women.
• Compressive optic neuropathy (e.g., orbital hematoma): Exclude acute compression due to post-traumatic orbital hematoma.
• Direct injury from globe rupture: Severe trauma with low intraocular pressure and globe deformation.

Q What is the swinging flashlight test?

A

It is the alternating light test, where a penlight is shone alternately into each eye to compare pupillary responses. When the light is moved to the eye with optic nerve damage, the pupil dilates (positive RAPD, Marcus Gunn pupil). It is the most important test for diagnosing traumatic optic neuropathy.

5. Standard Treatment

The goal of treatment for traumatic optic neuropathy is to rapidly and appropriately reduce and resolve edema within the optic nerve parenchyma. Early diagnosis and initiation of treatment (within 24 to 48 hours after injury) significantly affect the prognosis.

Pharmacotherapy (First-line)

Steroid pulse therapy: Intravenous infusion of prednisolone equivalent to 1,000 mg for 2 to 3 days.

High-dose steroid therapy: Administer prednisolone equivalent to 80 to 100 mg for 3 to 7 days, then taper gradually while monitoring visual acuity.

Hyperosmotic agents: Glycerol® or D-mannitol 300 to 500 mL for 3 to 7 days.

Purpose: To reduce and resolve vasogenic edema within the optic nerve parenchyma. Start as soon as the patient’s general condition allows.

Surgical Treatment

Optic canal decompression: Indications are controversial. It is limited to cases with marked deformity of the optic canal or significant displacement of bone fragments causing obvious optic nerve damage.

Endoscopic transnasal optic canal decompression: May be selected as a minimally invasive procedure.

Limitations of surgery: Many believe that surgery cannot achieve reduction of edema within the optic nerve parenchyma; decisions should be made in conjunction with pharmacotherapy.

Treatment Precautions

Cases where light perception loss does not recover quickly after injury are mostly unresponsive to treatment. There is currently no effective treatment for optic nerve avulsion, and the prognosis is poor. Steroid pulse therapy may be difficult to administer if the patient’s general condition is unstable.

Q When should steroid pulse therapy be started?

A

It is desirable to start within 24 to 48 hours after injury. Rapid reduction of edema within the optic nerve parenchyma affects the prognosis. Start steroid pulse therapy and hyperosmotic agents early, as long as the patient’s general condition allows. However, if light perception loss does not recover quickly after injury, the response to treatment is poor.

6. Prognosis and Follow-up

Approximately one year after injury is required for visual function to stabilize. Treatment response tends to correlate with the degree of visual function immediately after injury.

Cases in which light perception loss does not recover quickly after injury rarely respond to treatment. In such cases, it is difficult to expect recovery of visual function, and appropriate explanation and psychological support for the patient are important.

In optic nerve avulsion, the optic nerve is torn at the lamina cribrosa, and there is no effective treatment.

Serial evaluation of GCC thickness by OCT (thinning at 2 weeks post-injury, stabilization around 30–50 days) is useful for assessing the extent of nerve fiber damage and for follow-up. Regular fundus examination and OCT are recommended to monitor progression of optic atrophy.

7. Investigational Treatments and Findings

For patients: Please read carefully

The following content is currently under investigation or under discussion and is not standard treatment available at general hospitals. It is reference information for professionals regarding future medical developments.

Debate on evidence for steroid therapy

Evidence for high-dose steroids in traumatic optic neuropathy continues to be debated in relation to findings in traumatic spinal cord injury (e.g., NASCIS trials). Since the IONTS (International Optic Nerve Trauma Study), reports have shown no significant difference in visual prognosis among untreated, steroid, and optic canal decompression groups, and Cochrane systematic reviews and recent RCTs have not demonstrated clear efficacy ¹²³. Furthermore, the MRC CRASH trial in head injury reported a significant increase in mortality in the methylprednisolone group, highlighting the need for careful administration considering the presence of concomitant head injury ⁴⁵.

Endoscopic transnasal optic canal decompression

For endoscopic transnasal optic canal decompression as a minimally invasive procedure, further data accumulation on indications and long-term outcomes is needed. Although reports suggest higher improvement rates with early surgery (especially within 3 days) and in cases with residual visual function ⁶, meta-analyses comparing surgical decompression and conservative treatment have not yielded consistent results, and no randomized controlled trials have been established ⁷⁸.

OCT-A assessment of optic nerve blood flow

The use of optical coherence tomography angiography (OCT-A) to evaluate peripapillary blood flow is being investigated for its potential application in prognosis prediction and pathophysiological assessment of traumatic optic neuropathy.

---

References

Footnotes

1. Levin LA, Beck RW, Joseph MP, Seiff S, Kraker R. The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. Ophthalmology. 1999;106(7):1268-1277. PMID: 10406604. ↩

2. Yu-Wai-Man P, Griffiths PG. Steroids for traumatic optic neuropathy. Cochrane Database Syst Rev. 2013;(6):CD006032. PMID: 23771729. ↩

3. Blanch RJ, Joseph IJ, Cockerham K. Traumatic optic neuropathy management: a systematic review. Eye (Lond). 2024;38(12):2312-2318. PMID: 38862644. ↩

4. Roberts I, Yates D, Sandercock P, et al; CRASH trial collaborators. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet. 2004;364(9442):1321-1328. PMID: 15474134. ↩

5. Steinsapir KD, Goldberg RA. Traumatic optic neuropathy: an evolving understanding. Am J Ophthalmol. 2011;151(6):928-933.e2. PMID: 21529765. ↩

6. Yu B, Ma Y, Tu Y, Wu W. The Outcome of Endoscopic Transethmosphenoid Optic Canal Decompression for Indirect Traumatic Optic Neuropathy with No-Light-Perception. J Ophthalmol. 2016;2016:6492858. PMID: 27965891. ↩

7. Martinez-Perez R, Albonette-Felicio T, Hardesty DA, Carrau RL, Prevedello DM. Outcome of the surgical decompression for traumatic optic neuropathy: a systematic review and meta-analysis. Neurosurg Rev. 2021;44(2):633-641. PMID: 32088777. ↩

8. Fallahzadeh M, Veisi A, Tajari F, et al. The Management of Traumatic Optic Neuropathy: A Systematic Review and Meta-Analysis. Arch Acad Emerg Med. 2024;13(1):e19. PMID: 39670238. ↩